Many individuals are told that managing type 2 diabetes is simply a matter of controlling blood sugar. As long as glucos ...

Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...

A novel islet cell therapy delivered through a single infusion lowered HbA1c and eliminated severe hypoglycemia events for ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

As of December 31, 2024, LAVA had cash, cash equivalents, and investments of $76.6 million, compared to cash, cash equivalents, and investments of $95.6 million as of December 31, 2023. The Company ...

Exelixis, Inc. EXEL announced that the FDA has approved the label expansion of its lead drug Cabometyx (cabozantinib). The ...

In the latest installment of Healio’s video series with ASGE, Fiyinfoluwa O. Abraham, MD, discusses ethnic and racial disparities observed in the incidence of pancreatic cancer, demonstrating the need ...

Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo.

There's a lesser-known pancreatic cancer symptom that affects your legs that many people might not be wary of.

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer ...

Exelixis (EXEL) on Wednesday announced that the Food and Drug Administration has approved cabozantinib, or Cabometyx, for the treatment of ...

After canceling a planned advisory committee meeting, the FDA has approved Exelixis’ Cabometyx for neuroendocrine tumors. | ...